InvestorsHub Logo
Followers 4
Posts 217
Boards Moderated 0
Alias Born 03/18/2015

Re: None

Friday, 05/19/2017 5:08:32 PM

Friday, May 19, 2017 5:08:32 PM

Post# of 218
This bloated equity is in some serious trouble. Avita (AVMXY) just completed a successful P3 pivotal trial with Recell, and Renovacare, which trades at 10x the market cap, has yet to start a clinical trial! Add on top of that Avita holds patents that supercede Renovacare in the space. Renovacare is about to crash and burn IMHO.